Duration of neurofibrillary changes in the hippocampal pyramidal neurons (Q48430315)

11 February 2018

title

Duration of neurofibrillary changes in the hippocampal pyramidal neurons (English)

1 reference

11 February 2018

author

Barry Reisberg

5

1 reference

11 February 2018

author name string

Bobinski M

1

1 reference

11 February 2018

Wegiel J

2

1 reference

11 February 2018

Tarnawski M

3

1 reference

11 February 2018

de Leon MJ

4

1 reference

11 February 2018

Miller DC

6

1 reference

11 February 2018

Wisniewski HM

7

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

11 February 2018

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

11 February 2018

volume

799

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

156-158

1 reference

11 February 2018

Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Neuropathological stageing of Alzheimer-related changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Early marker for Alzheimer's disease: the atrophic hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Alzheimer neurofibrillary tangles: monoclonal antibodies to inherent antigen(s)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Unbiased stereological estimation of the number of neurons in the human hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

Alzheimer's neurofibrillary tangles are penetrated by astroglial processes and appear eosinophilic in their final stages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900441-7

10.1016/S0006-8993(98)00441-7

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018